Molecular mechanisms of glucocorticoids action: implications for treatment of rhinosinusitis and nasal polyposis

被引:26
|
作者
Grzanka, Alicja [1 ]
Misiolek, Maciej [2 ]
Golusinski, Wojciech [3 ]
Jarzab, Jerzy [1 ]
机构
[1] Med Univ Silesia, Clin Dept Internal Dis Dermatol & Allergol, PL-41800 Katowice, Poland
[2] Med Univ Silesia, Clin Dept Laryngol, PL-41800 Katowice, Poland
[3] Poznan Univ Med Sci, Greater Poland Canc Ctr, Dept Head & Neck Surg & Laryngol Oncol, Poznan, Poland
关键词
Glucocorticoids; Nongenomic and genomic action; Nasal polyps; Rhinitis; FLUTICASONE PROPIONATE; IN-VITRO; RECEPTOR; RHINITIS; UPDATE; DEXAMETHASONE; MANAGEMENT; SPRAY;
D O I
10.1007/s00405-010-1330-z
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Intra-nasal glucocorticoids are the most effective drugs available for rhinosinusitis and nasal polyposis treatment. Their effectiveness depends on many factors and not all of them have been well recognized so far. The authors present the basic information on molecular mechanisms of glucocorticoid action, direct and indirect effects of glucocorticoids on transcription of genes encoding inflammatory mediators. They focus on recently proved nongenomic mechanisms which appear quickly, from several seconds to minutes after glucocorticoid administration and discuss clinical implications resulting from this knowledge. Discovery of nongenomic glucocorticoid actions allows for better use of these drugs in clinical practice.
引用
收藏
页码:247 / 253
页数:7
相关论文
共 50 条
  • [31] T cells in chronic rhinosinusitis with nasal polyposis
    Ryan, Matthew W.
    Davis, Laurie S.
    CURRENT OPINION IN OTOLARYNGOLOGY & HEAD AND NECK SURGERY, 2010, 18 (03): : 200 - 205
  • [32] Chronic rhinosinusitis and nasal polyposis;: indicia of heterogeneity
    Bugten, Vegard
    Nordgard, Stale
    Romundstad, Pal
    Steinsvag, Sverre
    RHINOLOGY, 2008, 46 (01) : 40 - 44
  • [33] Polyposis nasi: chronic Rhinosinusitis with Nasal Polyps
    Josse, Sabine
    ALLERGO JOURNAL, 2019, 28 (04) : 48 - 48
  • [34] Surgical outcomes in chronic rhinosinusitis and nasal polyposis
    Lund, VJ
    RHINOLOGY, 2006, 44 (02) : 97 - 97
  • [35] Aspirin Desensitization in Treatment of Chronic Rhinosinusitis with Nasal Polyposis: Current Protocols and Evidence
    Thiagarajan, Kavitha
    Anderson, Lorraine
    CURRENT TREATMENT OPTIONS IN ALLERGY, 2024, 11 (03) : 123 - 135
  • [36] Current and future treatment options for adult chronic rhinosinusitis: Focus on nasal polyposis
    Bachert, Claus
    Zhang, Luo
    Gevaert, Phillippe
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 136 (06) : 1431 - 1440
  • [37] Efficacy and safety of erdosteine in the treatment of chronic rhinosinusitis with nasal polyposis - a pilot study
    Hoza, Jiri
    Salzman, Richard
    Starek, Ivo
    Schalek, Petr
    Kellnerova, Renata
    RHINOLOGY, 2013, 51 (04) : 323 - 327
  • [38] Response to treatment with dupilumab in patients with asthma and/or chronic rhinosinusitis and nasal polyposis (CRScNP)
    Arjona Hidalgo, A.
    Gonzalez Cuervo, H.
    Cuesta Apausa, M. D. P.
    Rodriguez Siverio, P.
    Hernandez Suarez, H. R.
    Santana Bordon, M.
    Parra Rojas, S.
    Carrillo Diaz, T.
    ALLERGY, 2023, 78 : 113 - 113
  • [39] Treatment of nasal polyposis and chronic rhinosinusitis with fluticasone propionate nasal drops reduces need for sinus surgery
    Aukema, AAC
    Mulder, PGH
    Fokkens, WJ
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2005, 115 (05) : 1017 - 1023
  • [40] Nasal-air conditioning in patients with chronic rhinosinusitis and nasal polyposis
    Papp, Judit
    Leiacker, Richard
    Keck, Tilman
    Rozsasi, Ajnacska
    Kappe, Thomas
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2008, 134 (09) : 931 - 935